Concepedia

Author

Debra Kelsh

Altasciences Clinical Research Vince & Associates

Also Known As

D. Kelsh, Debra Kelsh

22

Publications

416

Citations

9

H-Index

16

Concepts

All Affiliations

Altasciences Clinical Research Vince & AssociatesUniversity of TorontoSyneos Health (United States)University of KentuckyColumbia University
DK

About

Debra Kelsh is an author at Altasciences Clinical Research Vince & Associates specializing in opioid use disorder, health sciences, and smoking cessation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Health Sciences

1

1

23

2

Medicine

1

1

23

3

Pharmacology

1

1

23

4

Psychiatry

1

1

23

5

Behavioral Pharmacology

1

1

23

Debra Kelsh

×

9

Publications

388

Citations

9

H-Index

YearCitations

A randomized, double-blind, placebo-controlled, crossover study to evaluate the human abuse liability of solriamfetol, a selective dopamine and norepinephrine reuptake inhibitor

Lawrence P. Carter, Jack E. Henningfield, Y Grace Wang,

Journal of Psychopharmacology

2018

183

Effect of Buprenorphine Weekly Depot (CAM2038) and Hydromorphone Blockade in Individuals With Opioid Use Disorder

Sharon Walsh, Sandra D. Comer, Michelle R. Lofwall,

JAMA Psychiatry

2017

75

Abuse potential assessment of the new dual orexin receptor antagonist daridorexant in recreational sedative drug users as compared to suvorexant and zolpidem

Mike Ufer, Debra Kelsh, Kerri A. Schoedel,

SLEEP

2021

42

A randomized, double‐blind, placebo‐controlled study of the kappa opioid receptor antagonist, CERC‐501, in a human laboratory model of smoking behavior

Jermaine D. Jones, Shanna Babalonis, Ronald N. Marcus,

Addiction Biology

2019

23

Abuse potential of mirogabalin in recreational polydrug users

Jeanne Mendell, Naama Levy‐Cooperman, Ed Sellers,

Therapeutic Advances in Drug Safety

2019

18

Abuse Potential of Buprenorphine/Samidorphan Combination Compared to Buprenorphine and Placebo: A Phase 1 Randomized Controlled Trial

Sanjeev Pathak, Bradley Vince, Debra Kelsh,

The Journal of Clinical Pharmacology

2018

12

Abuse Potential of Samidorphan: A Phase I, Oxycodone‐, Pentazocine‐, Naltrexone‐, and Placebo‐Controlled Study

Sanjeev Pathak, Bradley Vince, Debra Kelsh,

The Journal of Clinical Pharmacology

2018

12

Phase I Pharmacokinetic Study of Fixed-Dose Combinations of Ibuprofen and Acetaminophen in Healthy Adult and Adolescent Populations

Sanela Tarabar, Debra Kelsh, Bradley Vince,

Drugs in R&D

2020

12

Oral, intranasal, and intravenous abuse potential of serdexmethylphenidate, a novel prodrug of d-methylphenidate

Megan J. Shram, Beatrice Setnik, Lynn R. Webster,

Current Medical Research and Opinion

2022

11

Page 1